Tenofovir alafenamide for prevention of HBV reactivation in HBsAg-negative, anti–HBc-positive patients undergoing rituximab-based chemotherapy: A multicenter randomized controlled trial
Year: 2025
Type: article
Language: en
Topic: Hepatitis B Virus Studies
Authors and affiliations:
raw_author_name: Sanam Tabataba Vakili
raw_affiliation_strings: Toronto Centre for Liver Disease, University Health Network, Toronto, Ontario, Canada
raw_author_name: Grishma Hirode
raw_affiliation_strings: Toronto Centre for Liver Disease, University Health Network, Toronto, Ontario, Canada
Viral Hepatitis Care Network (VIRCAN), University Health Network, Toronto, Ontario, Canada
raw_author_name: Atif Zahoor
raw_affiliation_strings: Toronto Centre for Liver Disease, University Health Network, Toronto, Ontario, Canada
raw_author_name: Ahreni Saunthar
raw_affiliation_strings: Toronto Centre for Liver Disease, University Health Network, Toronto, Ontario, Canada
raw_author_name: Joshua B. Feld
raw_affiliation_strings: Toronto Centre for Liver Disease, University Health Network, Toronto, Ontario, Canada
Viral Hepatitis Care Network (VIRCAN), University Health Network, Toronto, Ontario, Canada
raw_author_name: Bettina E. Hansen
raw_affiliation_strings: Erasmus University Medical Centre, Rotterdam, The Netherlands
Toronto Centre for Liver Disease, University Health Network, Toronto, Ontario, Canada
raw_author_name: Ambreen Syeda
raw_affiliation_strings: Toronto Centre for Liver Disease, University Health Network, Toronto, Ontario, Canada
raw_author_name: Harry L.A. Janssen
raw_affiliation_strings: Erasmus University Medical Centre, Rotterdam, The Netherlands
Toronto Centre for Liver Disease, University Health Network, Toronto, Ontario, Canada
raw_author_name: Vishal Kukreti
raw_affiliation_strings: Princess Margaret Cancer Centre, Toronto, Ontario, Canada
raw_author_name: John Kuruvilla
raw_affiliation_strings: Princess Margaret Cancer Centre, Toronto, Ontario, Canada
raw_author_name: Anca Prica
raw_affiliation_strings: Princess Margaret Cancer Centre, Toronto, Ontario, Canada
raw_author_name: Matthew Cheung
raw_affiliation_strings: Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada
raw_author_name: Rena Buckstein
raw_affiliation_strings: Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada
raw_author_name: Lisa Hicks
raw_affiliation_strings: Division of Hematology and Oncology, St. Michael’s Hospital, Toronto, Ontario, Canada
Division of Hematology and Oncology, St. Michael's Hospital, Toronto, Ontario, Canada
raw_author_name: Carla S. Coffin
raw_affiliation_strings: Division of Gastroenterology and Hepatology, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
raw_author_name: Lesley E. Street
raw_affiliation_strings: Division of Hematology and Hematologic Malignancies, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
raw_author_name: Patricia Disperati
raw_affiliation_strings: Michael Garron Hospital, Toronto, Ontario, Canada
raw_author_name: Kelvin K. Chan
raw_affiliation_strings: Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada
raw_author_name: Michael Crump
raw_affiliation_strings: Princess Margaret Cancer Centre, Toronto, Ontario, Canada
raw_author_name: Jordan J. Feld
raw_affiliation_strings: Toronto Centre for Liver Disease, University Health Network, Toronto, Ontario, Canada
Viral Hepatitis Care Network (VIRCAN), University Health Network, Toronto, Ontario, Canada